- Home
- ESPR vs WHF Comparison
ESPR vs WHF Comparison
Compare ESPR & WHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- WHF
- Stock Information
- Founded
- ESPR 2008
- WHF 2011
- Country
- ESPR United States
- WHF United States
- Employees
- ESPR N/A
- WHF N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- WHF Finance Companies
- Sector
- ESPR Health Care
- WHF Finance
- Exchange
- ESPR Nasdaq
- WHF Nasdaq
- Market Cap
- ESPR 208.1M
- WHF 212.0M
- IPO Year
- ESPR 2013
- WHF 2012
- Fundamental
- Price
- ESPR $1.07
- WHF $8.73
- Analyst Decision
- ESPR Buy
- WHF Sell
- Analyst Count
- ESPR 7
- WHF 4
- Target Price
- ESPR $5.93
- WHF $10.83
- AVG Volume (30 Days)
- ESPR 4.1M
- WHF 96.6K
- Earning Date
- ESPR 08-11-2025
- WHF 08-07-2025
- Dividend Yield
- ESPR N/A
- WHF 17.66%
- EPS Growth
- ESPR N/A
- WHF N/A
- EPS
- ESPR N/A
- WHF 0.39
- Revenue
- ESPR $259,574,000.00
- WHF $86,143,000.00
- Revenue This Year
- ESPR $4.07
- WHF N/A
- Revenue Next Year
- ESPR N/A
- WHF N/A
- P/E Ratio
- ESPR N/A
- WHF $22.16
- Revenue Growth
- ESPR 12.99
- WHF N/A
- 52 Week Low
- ESPR $0.69
- WHF $8.44
- 52 Week High
- ESPR $3.94
- WHF $12.73
- Technical
- Relative Strength Index (RSI)
- ESPR 51.40
- WHF 38.47
- Support Level
- ESPR $1.13
- WHF $9.18
- Resistance Level
- ESPR $1.22
- WHF $9.66
- Average True Range (ATR)
- ESPR 0.08
- WHF 0.16
- MACD
- ESPR 0.00
- WHF -0.00
- Stochastic Oscillator
- ESPR 52.38
- WHF 0.00
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About WHF WhiteHorse Finance Inc.
WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate risk-adjusted returns by originating and investing in senior secured loans, including first lien and second lien facilities, to performing lower middle market companies across a range of industries.